merged_africa-snakebite-treatment-access.txt
<other>Analyzing the article to extract relevant information for each question.</other>  
<question_number>1</question_number>  
<answer>The venom likely caused severe tissue necrosis and damage, which progressed despite antivenom administration, necessitating amputation.</answer>  
<question_number>2</question_number>  
<answer>Venom variation across regions and species means Indian-manufactured antivenom, tailored for kraits, is ineffective against Kenyan puff adders.</answer>  
<question_number>3</question_number>  
<answer>Snake venoms contain diverse toxins, including neurotoxins and hemotoxins, which current antivenoms cannot universally neutralize, necessitating monoclonal antibodies targeting these toxin families.</answer>  
<question_number>4</question_number>  
<answer>Spitting cobras can spray venom into eyes, mimicking non-venomous ocular injuries, which may lead to misdiagnosis in areas reliant on traditional healers.</answer>  
<question_number>5</question_number>  
<answer>Seasonal flooding and dry periods drive snakes closer to human settlements and farms, increasing risk for farmers and rural residents during these times.</answer>  
<question_number>6</question_number>  
<answer>Black mambas have highly toxic neurotoxic venom, long reach due to their size, and rapid striking ability, enabling faster fatal envenomation compared to puff adders.</answer>  
<question_number>7</question_number>  
<answer>Antivenom's need for refrigeration and delays in reaching hospitals within the six-hour window exacerbate poor outcomes for pregnant victims in Kenya.</answer>  
<question_number>8</question_number>  
<answer>Tourniquets and traditional treatments often worsen outcomes by cutting off blood flow or delaying proper care, compounding venom's effects.</answer>  